Company Filing History:
Years Active: 2020
Title: Nicola Angelo Maria Volpi: Innovator in Biotechnological Chondroitin Sulfate
Introduction
Nicola Angelo Maria Volpi is a notable inventor based in Modena, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of chondroitin sulfate with therapeutic applications.
Latest Patents
Volpi holds a patent for "Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis." This innovative product is characterized by a low molecular weight ranging from 1000 to 5000 daltons. It is produced through the chemical sulfation of a non-sulfated chondroitin backbone, specifically the K4 capsular polysaccharide, which is obtained using advanced biotechnology techniques. The resulting chondroitin sulfate is primarily monosulfated at the 6-position, with minimal sulfation at the 4-position. This formulation exhibits a mono/disulfated disaccharide ratio and charge density that closely resembles natural chondroitin sulfate. It is particularly useful in treating and preventing osteoarthritis, as well as in managing acute and chronic inflammatory processes.
Career Highlights
Volpi is associated with Gnosis Spa, where he applies his expertise in biotechnology to develop innovative solutions. His work has positioned him as a key figure in the field, contributing to advancements that have the potential to improve patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including Paola Bazza and Davide Bianchi, who share his commitment to advancing biotechnological research and applications.
Conclusion
Nicola Angelo Maria Volpi's contributions to the field of biotechnology, particularly through his patented chondroitin sulfate, highlight his role as an innovator dedicated to improving health outcomes. His work continues to influence the landscape of biotechnological advancements.